Network origin in Le-Van Nguyen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 16 | |
CoMentis, Inc.
CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.
9
| Extinct | Pharmaceuticals: Major | 9 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
7
| Extinct | Pharmaceuticals: Major | 7 |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA.
2
| Extinct | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Le-Van Nguyen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman | |
Aerogen, Inc.
Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | President | |
ZS PHARMA INC | Pharmaceuticals: Major | Chief Administrative Officer Human Resources Officer | |
ALZHEON, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
The University of Texas at Austin | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
St. Mary's College of California | College/University | Corporate Officer/Principal Undergraduate Degree | |
San Jose State University | College/University | Graduate Degree Undergraduate Degree | |
University of California, Davis | College/University | Graduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schwartz Pharma AG
Schwartz Pharma AG Pharmaceuticals: MajorHealth Technology Schwartz Pharma AG is a German company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Gothenburg | College/University | Doctorate Degree | |
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member | |
Prothena Biosciences, Inc.
Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Chairman | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | General Counsel Comptroller/Controller/Auditor | |
OBSEVA SA | Pharmaceuticals: Major | Chairman | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CARDAX, INC. | Pharmaceuticals: Major | Director/Board Member | |
4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer President | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
Perception Neuroscience, Inc.
Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
United States | 40 |
Ireland | 3 |
Germany | 3 |
Denmark | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 35 |
Consumer Services | 11 |
Commercial Services | 2 |
Finance | 2 |
Health Services | 2 |
Operational
Director/Board Member | 166 |
Corporate Officer/Principal | 64 |
Independent Dir/Board Member | 64 |
Chief Tech/Sci/R&D Officer | 35 |
Chief Executive Officer | 29 |
Most connected contacts
Insiders | |
---|---|
Jonathan Leff | 45 |
Jay Shepard | 30 |
Mary Gray | 27 |
Jean-Jacques Bienaimé | 21 |
Lars Ekman | 21 |
Frank Verwiel | 16 |
Stephen Dilly | 15 |
Angus Russell | 14 |
Muralitharan Ken Kengatharan | 14 |
Robert W. Frick | 14 |
Jonathan Leff | 14 |
Paul D. Arata | 11 |
Robert Fishman | 11 |
Martin Tolar | 10 |
James J. L'Italien | 10 |
- Stock Market
- Insiders
- Le-Van Nguyen
- Company connections